John Harkey Jr.

Mr. Harkey is the Founder of JDH Investment Management, LLC, which is focused on leading innovative and impactful opportunities in the biotechnology industry. Notably, he was the Co-founder and Executive Chairman of AveXis, which was acquired by Novartis for $8.7bn in 201B. He currently serves as Co-founder, Board Member and Co-CEO of Cessation Therapeutics. He also served on the board of CerSci Therapeutics until recent acquisition by Acadia Pharmaceuticals and on the board of directors of Emisphere Technologies until its recent acquisition by Novo Nordisk Mr. Harkey received a B.B.A. in Business Honors and a J.D. from the University OF Texas at Austin, and an M.B.A. from Stanford University School of Business.